Angiogenesis 2024: AVD-104 for Geographic Atrophy

Carl Danzig, MD, sat down with Martin David Harp of Ophthalmology Times to discuss his presentation AVD-104 for Geographic Atrophy: Glyco-immunologic modulation of macrophage activity from the Angiogenesis Exudation and Degeneration 2024 event.

Related Videos

Related Content

Advertisement

November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

November 13th 2024

Study examines the use of AI–based detection of diabetic retinopathy in the US

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

November 8th 2024

Researchers offer insights into wet AMD: Study reveals potential to enhance anti-VEGF therapy with experimental drug to preserve vision

November 6th 2024

FDA grants fast track status to FELIQS’ FLQ-101 for ROP

Related Content

Advertisement

November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

November 13th 2024

Study examines the use of AI–based detection of diabetic retinopathy in the US

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

November 8th 2024

Researchers offer insights into wet AMD: Study reveals potential to enhance anti-VEGF therapy with experimental drug to preserve vision

November 6th 2024

FDA grants fast track status to FELIQS’ FLQ-101 for ROP